+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Novel benzoxazole inhibitors of mPGES-1

Novel benzoxazole inhibitors of mPGES-1

Bioorganic & Medicinal Chemistry Letters 23(3): 907-911

A novel series of potent benzoxazole mPGES-1 inhibitors has been derived from a hit from a high throughput screen. Compound 37 displays mPGES-1 inhibition in an enzyme assay (0.018 μM) and PGE-2 inhibition in a cell-based assay (0.034 μM). It demonstrates 500- and 2500-fold selectivity for mPGES-1 over COX-2 and 6-keto PGF-1α, respectively. In vivo PK studies in dogs demonstrate 55% oral bioavailability and an 7 h half-life.

(PDF same-day service: $19.90)

Accession: 054669412

Download citation: RISBibTeXText

PMID: 23266122

DOI: 10.1016/j.bmcl.2012.10.040

Related references

Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX). Journal of Medicinal Chemistry 52(15): 4968-4972, 2009

Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? The Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors. Journal of Natural Products 78(12): 2867-2879, 2016

The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas. Neuropathology 29(2): 156-165, 2009

Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts. American Journal of Physiology. Heart and Circulatory Physiology 288(1): H165-H174, 2004

Pulmonary and cardiorenal cyclooxygenase-1 (COX-1), -2 (COX-2), and microsomal prostaglandin E synthase-1 (mPGES-1) and -2 (mPGES-2) expression in a hypertension model. Mediators of Inflammation 2007: 85091-85091, 2007

Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation. Prostaglandins & Other Lipid Mediators 107: 26-34, 2014

Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue. Laboratory Investigation; A Journal of Technical Methods and Pathology 85(2): 225-236, 2004

Identification and development of mPGES-1 inhibitors: where we are at?. Future Medicinal Chemistry 3(15): 1909-1934, 2012

Identification of novel mPGES-1 inhibitors through screening of a chemical library. Bioorganic & Medicinal Chemistry Letters 22(24): 7335-7339, 2013

Toward the management of inflammation: recent developments of mPGES-1 inhibitors. Recent Patents on Cns Drug Discovery 5(1): 70-80, 2010

Trisubstituted ureas as potent and selective mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 21(5): 1488-1492, 2011

Reaction of the 2- benzoxazole with tetrakis ethylene in the presence of aldehydes A convenient synthesis of 2- benzoxazole alcohols. Tetrahedron Letters 38(5): 821-824, 1997

Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorganic & Medicinal Chemistry Letters 15(14): 3352-3355, 2005

Semisynthetic and Natural Garcinoic Acid Isoforms as New mPGES-1 Inhibitors. Planta Medica 82(11-12): 1110-1116, 2016